Letter to the Editor regarding: “Pre- and post-analytical guidelines for the microscopic diagnosis of melanoma: recommendations from the Brazilian Society of Pathology” – Reply
José Cândido Caldeira Xavier-Júnior, Karina Munhoz de Paula Alves Coelho, Mariana Petaccia de Macedo, Rute Facchini Lellis, Nathanael de Freitas Pinheiro Junior, Robledo Fonseca Rocha

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCutaneous Melanoma Detection and Management · melanin and skin pigmentation · Nonmelanoma Skin Cancer Studies
Dear Editor,
We read with great interest the letter from Dr. Cunha regarding our recently published guideline.1 Both the College of American Pathologists2 and the NCCN3 strongly discourage the use of frozen sections for most melanocytic lesions when standard clinical margins can be achieved without significant limitations. They emphasize that accurate melanoma diagnosis continues to rely on Hematoxylin and Eosin (H&E) sections from formalin-fixed, paraffin-embedded tissue, supplemented, when appropriate, by immunohistochemistry,2, 3, 4 since melanoma represents a heterogeneous group of tumors with multiple histologic subtypes and distinct biological behaviors.4
The recommended peripheral surgical margins and methods for their assessment in head and neck melanoma and lentigo maligna remain subjects of considerable debate. This uncertainty largely reflects the lack of consistent, well-designed prospective studies addressing the management of these challenging lesions. A recent critical review identified a very high risk of bias (97.9%) among studies evaluating Mohs Micrographic Surgery (MMS) for melanoma.5
Although robust validation for the use of MMS in melanocytic lesions is still lacking, recent advances in this field deserve recognition. According to the latest NCCN guidelines for cutaneous melanoma, MMS ‒ or other techniques that enable comprehensive margin assessment ‒ may provide equivalent or even superior local control for certain pT1a melanomas in selected sites, particularly on the face, ears, and acral areas.3 It is essential, however, that potential candidates be carefully selected and thoroughly counseled. The successful use of these techniques, which apply only to a small subset of melanoma patients, requires a well-trained and experienced multidisciplinary team. It is important to highlight that, considering melanomas arising in skin with extensive cumulative sun damage, histopathologic interpretation can be especially challenging. This difficulty arises from actinic melanocytic alterations and ill-defined tumor margins with “skip” areas4 ‒ factors that may be further compounded by technically suboptimal slides.
Finally, as also acknowledged by the NCCN,3 no prospective comparative studies have yet evaluated the different excision methods for melanoma. This gap leaves the topic open for continued scientific discussion. Future prospective, independent, and well-designed studies are needed to clarify the potential role of MMS and other surgical techniques in the management of melanocytic lesions.
Financial support
None declared.
Authors’ contributions
José Cândido Caldeira Xavier Junior: Contributed to the design and planning of the study; drafting, editing, or critically reviewing the manuscript for important intellectual content; active participation in research supervision; critical review of the literature; and approval of the final version of the manuscript.
Karina Munhoz de Paula Alves Coelho: Contributed to the design and planning of the study; drafting, editing, or critically reviewing the manuscript for important intellectual content; active participation in research supervision; critical review of the literature; and approval of the final version of the manuscript.
Mariana Petaccia de Macedo: Contributed to the design and planning of the study; drafting, editing, or critically reviewing the manuscript for important intellectual content; active participation in research supervision; critical review of the literature; and approval of the final version of the manuscript.
Rute Facchini Lellis: Contributed to the design and planning of the study; drafting, editing, or critically reviewing the manuscript for important intellectual content; active participation in research supervision; critical review of the literature; and approval of the final version of the manuscript.
Nathanael de Freitas Pinheiro Junior: Contributed to the design and planning of the study; drafting, editing, or critically reviewing the manuscript for important intellectual content; active participation in research supervision; critical review of the literature; and approval of the final version of the manuscript.
Robledo Fonseca Rocha: Contributed to the design and planning of the study; drafting, editing, or critically reviewing the manuscript for important intellectual content; active participation in research supervision; critical review of the literature; and approval of the final version of the manuscript.
ORCID ID
Mariana Petaccia de Macedo: 0000-0002-0434-7605
Rute Facchini Lellis: 0000-0001-7690-0513
Nathanael de Freitas Pinheiro Junior: 0000-0003-0691-3006
Robledo Fonseca Rocha: 0009-0000-0083-8434
Research data availability
Does not apply.
Conflicts of interest
None declared.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Xavier-Júnior J.C.C.Coelho K.M.P.A.Macedo M.P.Lellis R.F.Pinheiro Junior N.F.Rocha R.F.Dermatopathology Committee of the Brazilian Society of Pathology Pre-and post-analytical guidelines for the microscopic diagnosis of melanoma: recommendations from the brazilian society of pathology An Bras Dermatol.100202550113910.1016/j.abd.2025.501139 PMC 1227078040614549 · doi ↗ · pubmed ↗
- 2College of American Pathologists Protocol for the Examination of Excision Specimens from Patients with Invasive Melanoma of the Skin 2025 Version 1.2.0.0
- 3NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Melanoma: cutaneous 2025 Version 2. 2025
- 4WHO Classification of Tumours Editorial Board. Skin Tumours 5th ed 2025 International Agency for Research on Cancer Lyon (France)
- 5Adalsteinsson J.A.Stoj V.J.Algzlan H.Swede H.Torbeck R.L.Ratner D.Limitations in the literature regarding mohs surgery and staged excision for melanoma: a critical review of quality and data reporting J Am Acad Dermatol.8820234044133387271510.1016/j.jaad.2021.02.091 · doi ↗ · pubmed ↗
